The expression of angiogenin in tissue samples of different brain tumours and cultured glioma cells

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1679-1684

  Eberle, Katharina ^a   Oberpichler, Andre ^b   Trantakis, Christos ^a   Krupp, Wolfgang ^a   Knüpfer, Matthias ^a   Tschesche, Harald ^b   Seifert, Volker ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

Author keywords

Angiogenesis; ELISA; Glioma cell culture; Immunoblotting; Tmour progression

Indexed keywords

ANGIOGENIN;

ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; BRAIN TUMOR; CANCER CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MENINGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BRAIN NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIOMA; HUMANS; MODELS, MOLECULAR; RIBONUCLEASE, PANCREATIC; TUMOR CELLS, CULTURED;

EID: 0033863824     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Halaka AN, Brunnina RAD, Bird CC, Gibson M, Reynolds JJ: Production of collagenase and inhibitor (TIMP) by intracranial tumours and dura in vitro. J Neurosurg 59: 461-466, 1983.
2. Matsuzawa K, Fukuyama K, Hubbard SL, Dirks PB, Rutka JT: Transfection of an invasive human astrocytoma cell line with a TIMP-1 cDNA - modulation of astrocytoma invasive potential. J Neuropathol Exp Neurol 55: 88-96, 1996.
3. Kim SC, Singh M, Huang J, Prestigiacomo CJ, Winfree CJ, Solomon RA, Conolly ES: Matrix metalloproteinase 4 in cerebral aneurysms. Neurosurgery 41: 642-647, 1997.
4. Chambers AF, Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis: J Natl Cancer Inst 89: 1260-1270, 1997.
5. Rybak SM, Fett JW, Yao QZ, Vallee BL: Angiogenin m-RNA in human tumour and normal cells: Biochem Biophys Res Commun 146: 1240-1248, 1987.
6. Shimoyana S, Gansauge F, Negri G, Oohara T, Berger HG: Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res 56: 2703-2706, 1996.
7. Rooprai H, McCormick D: Proteases and their inhibitors in human brain tumours a review. Anticancer Res 17: 4151-4162, 1997.
8. Folkmann J, Shing Y: Angiogenesis. J Biol Chem 267: 10931-10934, 1992.
9. Cockerill GW, Gamble JR, Vadas MA: Angiogenesis - models and modulators. Int Rev Cytol 159: 113-160, 1995.
10. Folkman J, Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1987.
11. Fett JW, Strydom, DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF Vallee BL: Isolation and characterisation of angiogenin, an angiogenic protein from human carcinoma cells: Biochemistry 24: 5480-5486, 1985.
12. Denefle P, Kovarik S, Guitton JD, Cartwright T, Mayaux JF: Chemical synthesis of a gene coding for human angiogenin expression in Escherichia coli and conversion of the product into its active form. Gene (Amst) 56: 61-70, 1987.
13. Shapiro R, Strydom DJ, Olson KA, Vallee BL: Isolation of angiogenin from normal human plasma. Biochemistry 26: 5141-5146, 1987.
14. Olson KA, Fett JW, French TC, Key ME, Vallee BL: Angiogenin antagonists prevent tumour growth in vitro. Proc Natl Acad Sci 92: 442-446, 1995.
15. Moenner M, Gusse M, Hatzl E, Badet J: The widespread expression of angiogenin in different human cells suggest a biological function not only related to angiogenesis. Eur J Biochem 226: 483-490, 1994.
16. Hu G, Riordan JF, Vallee BL: Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-assiociated proteolytic activities. Biochemistry 91: 12096-12100, 1994.
17. Olson KA, French TC, Vallee BL, Fett JW: A monoclonal antibody to human angiogenin suppresses tumour growth in athymic mice. Cancer Res 54: 4576-4579, 1994.
18. Blaser J, Triebel S, Kopp C, Tscheche H: A highly sensitive immuno-enzymometric assay for determination of angiogenin. Eur J Clin Biochem 31: 513-516, 1993.
19. Imai F, Marunouchi T, Mizoguchi Y, Ogasawara M, Kanno T: Phenotypic alteration of glioma cells during culture. Brain Tumour Pathol 10: 19-25, 1993.
20. Bradford MM: A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72: 248-254, 1976.
21. Sukuzi K.. Enahild JJ, Morodomi T, Salvesen G, Nagase H: Mechanisms of activation of tissue procollagenase by matrix metallo-proteinase 3 (Stromolysin). Biochemistry 29: 10261-10270, 1990.
22. Hu GF, Riordan JF, Vallee B: A putative angiogenin receptor in angiogenin responsive human endothelial cells. Proc Natl Acad Sci USA 94: 2204-2209, 1997.
23. Blaser J, Thomssen C, Schmitt M, Pache L, Janicke F, Graeff H, Tschesche H: Angiogenin is a valuable prognostic factor in node-negative breast cancer. In: Prospects in Diagnosis and treatment of breast cancer (Schmitt M, Graeff H, Kindermann G, eds.) London, Excerpta medica, 1994, pp 223-227.
24. Tschesche H, Kopp C, Horl WH, Hempelmann U: Inhibition of degranulation of polymorphonuclear leucocytes by angiogenin and its tryptic fragment. J Biol Chem 269(48): 30274-30280, 1994.
25. Kleihues, P, Soylemezoglu F, Schauble B, Scheithauer BW, Burger PC: Histopathologie, classification and grading of gliomas. Glia 15: 211-221, 1995.
26. Rossi M, Rooprai HK, Maidment SL, Rucklidge GJ, Piklington GJ: The influence of sequential in vitro passage on secretion of matrix metalloproteinases by human brain tumours. Anticancer Res 16: 121-128, 1996.